Patents by Inventor Mihwa Kim

Mihwa Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GFRalpha1 AS A BIOMARKER FOR CISPLATIN-INDUCED CHEMORESISTANCE AND METASTASIS
    Publication number: 20180171411
    Abstract: Certain embodiments are directed to methods and composition for detecting the level of GFR?1 in cancers and treating same.
    Type: Application
    Filed: June 10, 2016
    Publication date: June 21, 2018
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Dae Joon KIM, Mihwa KIM, Thomas J. SLAGA, Won Jae KIM, Jin-Yeon JUNG
  • DIAGNOSIS AND THERAPY OF ORGAN DYSFUNCTION USING SPHINGANINE-1-PHOSPHATE
    Publication number: 20110294874
    Abstract: The invention relates to the treatment and diagnosis of organ dysfunction caused by ischemia reperfusion injury. In particular, the invention relates to sphinganine-1-phosphate, a sphingolipid metabolite, and its use in the diagnosing, preventing, and/or treating ischemia reperfusion-associated disorders, including, without limitation, disorders of the kidney, liver, lung, brain, and heart.
    Type: Application
    Filed: December 9, 2009
    Publication date: December 1, 2011
    Applicant: The Trustees of Columbia University in the City of New York
    Inventors: H. Thomas Lee, Mihwa Kim